We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$55B
AUM Growth
+$6.6B
Cap. Flow
+$2.65B
Cap. Flow %
4.81%
Top 10 Hldgs %
35.14%
Holding
929
New
47
Increased
589
Reduced
189
Closed
58

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$255M
2
AAPL icon
Apple
AAPL
+$173M
3
MSFT icon
Microsoft
MSFT
+$166M
4
JPM icon
JPMorgan Chase
JPM
+$134M
5
AMZN icon
Amazon
AMZN
+$101M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$74.8M
2
ACN icon
Accenture
ACN
+$70.7M
3
ELV icon
Elevance Health
ELV
+$69.2M
4
HES
Hess
HES
+$59.9M
5
MSI icon
Motorola Solutions
MSI
+$53.7M

Sector Composition

Rank Sector Weight
1 Technology 34.07%
2 Financials 13.98%
3 Consumer Discretionary 10.82%
4 Communication Services 10.11%
5 Healthcare 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESS icon
476
Essex Property Trust
ESS
$18.9B
$13M 0.02%
48,488
+522
+1% +$141K
INVH icon
477
Invitation Homes
INVH
$17.7B
$12.9M 0.02%
439,988
+3,377
+0.8% +$104K
DOW icon
478
Dow Inc
DOW
$21.6B
$12.9M 0.02%
562,064
+36,309
+7% +$905K
TOST icon
479
Toast
TOST
$16.8B
$12.8M 0.02%
350,077
+24,964
+8% +$1.08M
IMO icon
480
Imperial Oil
IMO
$62.1B
$12.8M 0.02%
141,063
+8,856
+7% +$765K
BURL icon
481
Burlington
BURL
$22B
$12.7M 0.02%
49,792
+3,009
+6% +$817K
DKNG icon
482
DraftKings
DKNG
$11.4B
$12.6M 0.02%
336,959
+24,651
+8% +$1.09M
IFF icon
483
International Flavors & Fragrances
IFF
$19.4B
$12.5M 0.02%
202,935
+12,701
+7% +$872K
MMYT icon
484
MakeMyTrip
MMYT
$4.67B
$12.5M 0.02%
133,233
+26,324
+25% +$2.56M
SUI icon
485
Sun Communities
SUI
$15B
$12.4M 0.02%
96,239
+1,034
+1% +$131K
CHRW icon
486
C.H. Robinson
CHRW
$22B
$12.4M 0.02%
93,715
+14
+0% +$1.64K
TXT icon
487
Textron
TXT
$16.6B
$12.4M 0.02%
146,229
+9,031
+7% +$735K
MAA icon
488
Mid-America Apartment Communities
MAA
$15.6B
$12.3M 0.02%
88,241
+967
+1% +$140K
EQH icon
489
Equitable Holdings
EQH
$13.1B
$12.3M 0.02%
242,642
+9,509
+4% +$504K
BBY icon
490
Best Buy
BBY
$18B
$12.3M 0.02%
162,887
-4,300
-3% -$308K
ILMN icon
491
Illumina
ILMN
$29.4B
$12.3M 0.02%
129,510
+12,585
+11% +$1.25M
TWLO icon
492
Twilio
TWLO
$29.1B
$12.1M 0.02%
120,719
+10,494
+10% +$1.18M
CLX icon
493
Clorox
CLX
$11.6B
$12.1M 0.02%
97,952
+5,749
+6% +$714K
DOCU
494
DocuSign
DOCU
$9.63B
$12M 0.02%
166,719
+10,193
+7% +$786K
ZBRA icon
495
Zebra Technologies
ZBRA
$12.4B
$12M 0.02%
40,333
+2,448
+6% +$782K
HOLX
496
DELISTED
Hologic
HOLX
$12M 0.02%
177,393
+10,381
+6% +$689K
OKTA icon
497
Okta
OKTA
$24.1B
$12M 0.02%
130,452
+7,847
+6% +$733K
INCY icon
498
Incyte
INCY
$23.5B
$11.9M 0.02%
140,644
+20,314
+17% +$1.61M
OMC icon
499
Omnicom Group
OMC
$22.7B
$11.9M 0.02%
146,157
+905
+0.6% +$68.3K
CF icon
500
CF Industries
CF
$19.2B
$11.9M 0.02%
132,393
+2,582
+2% +$230K

Similar funds

Aviva's Q3 2025 Portfolio in Review

As of Q3 2025, Aviva held 929 positions worth $55B, up 14% from $48.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Aviva deployed $2.65B of net new capital in Q3 2025, opening 47 new positions and adding to 589 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Otis Worldwide, an estimated $74.8M trimmed.

  • Aviva's largest Q3 2025 buy was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.
  • Aviva added most to NVIDIA in Q3 2025, an estimated $255M increase.
  • Aviva's biggest Q3 2025 reduction was Otis Worldwide, cutting an estimated $74.8M.
  • Aviva fully exited Hess in Q3 2025, selling an estimated $59.9M.
  • Aviva's ten largest holdings make up 35% of its $55B portfolio in Q3 2025.
  • Aviva opened 47 new positions and closed 58 in Q3 2025.
  • Aviva's portfolio value rose 14% quarter-over-quarter to $55B.

Based on Aviva's 13F filing for Q3 2025, filed 13 Nov 2025.